0001437749-23-004161.txt : 20230222 0001437749-23-004161.hdr.sgml : 20230222 20230222163005 ACCESSION NUMBER: 0001437749-23-004161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230217 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sellers Bakari T. CENTRAL INDEX KEY: 0001721556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38299 FILM NUMBER: 23653591 MAIL ADDRESS: STREET 1: 4231 VOORHEES ROAD CITY: DENMARK STATE: SC ZIP: 29042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: cbdMD, Inc. CENTRAL INDEX KEY: 0001644903 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 473414576 STATE OF INCORPORATION: NC FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8845 RED OAK BOULEVARD CITY: CHARLOTTE STATE: NC ZIP: 28217 BUSINESS PHONE: 704-445-3060 MAIL ADDRESS: STREET 1: 8845 RED OAK BOULEVARD CITY: CHARLOTTE STATE: NC ZIP: 28217 FORMER COMPANY: FORMER CONFORMED NAME: Level Brands, Inc. DATE OF NAME CHANGE: 20170202 FORMER COMPANY: FORMER CONFORMED NAME: LEVEL BEAUTY GROUP, INC. DATE OF NAME CHANGE: 20150611 4 1 rdgdoc.xml FORM 4 X0306 4 2023-02-17 0001644903 cbdMD, Inc. YCBD 0001721556 Sellers Bakari T. C/O 8845 RED OAK BOULEVARD CHARLOTTE NC 28217 1 Common Stock 2023-02-17 4 A 0 5000 0 A 17531 D Stock Options (Right to Buy) 0.28 2023-02-17 4 A 0 30000 A 2023-02-17 2028-02-17 Common Stock 30000 30000 D The restricted shares of common stock were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted shares of common stock vest quarterly in equal increments on June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024, subject to continued service as a director of the Issuer on each applicable vesting date. The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested. Not applicable. /s/ Bakari T. Sellers 2023-02-22